These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 30788385)

  • 1. AAV9-
    Suzuki-Hatano S; Saha M; Soustek MS; Kang PB; Byrne BJ; Cade WT; Pacak CA
    Mol Ther Methods Clin Dev; 2019 Jun; 13():167-179. PubMed ID: 30788385
    [TBL] [Abstract][Full Text] [Related]  

  • 2. AAV-Mediated TAZ Gene Replacement Restores Mitochondrial and Cardioskeletal Function in Barth Syndrome.
    Suzuki-Hatano S; Saha M; Rizzo SA; Witko RL; Gosiker BJ; Ramanathan M; Soustek MS; Jones MD; Kang PB; Byrne BJ; Cade WT; Pacak CA
    Hum Gene Ther; 2019 Feb; 30(2):139-154. PubMed ID: 30070157
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tafazzin deficiency causes substantial remodeling in the lipidome of a mouse model of Barth Syndrome cardiomyopathy.
    Hachmann M; Gülcan G; Rajendran R; Höring M; Liebisch G; Bachhuka A; Kohlhaas M; Maack C; Ergün S; Dudek J; Karnati S
    Front Mol Med; 2024; 4():1389456. PubMed ID: 39086433
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased mtDNA Abundance and Improved Function in Human Barth Syndrome Patient Fibroblasts Following AAV-
    Suzuki-Hatano S; Sriramvenugopal M; Ramanathan M; Soustek M; Byrne BJ; Cade WT; Kang PB; Pacak CA
    Int J Mol Sci; 2019 Jul; 20(14):. PubMed ID: 31336787
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Restoration of mitophagy ameliorates cardiomyopathy in Barth syndrome.
    Zhang J; Liu X; Nie J; Shi Y
    Autophagy; 2022 Sep; 18(9):2134-2149. PubMed ID: 34985382
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phospholipid abnormalities in children with Barth syndrome.
    Schlame M; Kelley RI; Feigenbaum A; Towbin JA; Heerdt PM; Schieble T; Wanders RJ; DiMauro S; Blanck TJ
    J Am Coll Cardiol; 2003 Dec; 42(11):1994-9. PubMed ID: 14662265
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of novel mitochondrial localization signals in human Tafazzin, the cause of the inherited cardiomyopathic disorder Barth syndrome.
    Dinca AA; Chien WM; Chin MT
    J Mol Cell Cardiol; 2018 Jan; 114():83-92. PubMed ID: 29129703
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardiolipin Remodeling Defects Impair Mitochondrial Architecture and Function in a Murine Model of Barth Syndrome Cardiomyopathy.
    Zhu S; Chen Z; Zhu M; Shen Y; Leon LJ; Chi L; Spinozzi S; Tan C; Gu Y; Nguyen A; Zhou Y; Feng W; Vaz FM; Wang X; Gustafsson AB; Evans SM; Kunfu O; Fang X
    Circ Heart Fail; 2021 Jun; 14(6):e008289. PubMed ID: 34129362
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Barth Syndrome Patient-Derived
    Snider PL; Sierra Potchanant EA; Sun Z; Edwards DM; Chan KK; Matias C; Awata J; Sheth A; Pride PM; Payne RM; Rubart M; Brault JJ; Chin MT; Nalepa G; Conway SJ
    Int J Mol Sci; 2024 Jul; 25(15):. PubMed ID: 39125771
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tafazzin deficiency impairs CoA-dependent oxidative metabolism in cardiac mitochondria.
    Le CH; Benage LG; Specht KS; Li Puma LC; Mulligan CM; Heuberger AL; Prenni JE; Claypool SM; Chatfield KC; Sparagna GC; Chicco AJ
    J Biol Chem; 2020 Aug; 295(35):12485-12497. PubMed ID: 32665401
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of human monolysocardiolipin acyltransferase-1 improves mitochondrial function in Barth syndrome lymphoblasts.
    Mejia EM; Zegallai H; Bouchard ED; Banerji V; Ravandi A; Hatch GM
    J Biol Chem; 2018 May; 293(20):7564-7577. PubMed ID: 29563154
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Barth syndrome-related cardiomyopathy is associated with a reduction in myocardial glucose oxidation.
    Greenwell AA; Gopal K; Altamimi TR; Saed CT; Wang F; Tabatabaei Dakhili SA; Ho KL; Zhang L; Eaton F; Kruger J; Al Batran R; Lopaschuk GD; Oudit GY; Ussher JR
    Am J Physiol Heart Circ Physiol; 2021 Jun; 320(6):H2255-H2269. PubMed ID: 33929899
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of a Novel De Novo Mutation of the TAZ Gene in a Korean Patient with Barth Syndrome.
    Yoo TY; Kim MR; Son JS; Lee R; Bae SH; Chung S; Kim KS; Seong MW; Park SS
    J Cardiovasc Ultrasound; 2016 Jun; 24(2):153-7. PubMed ID: 27358708
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Barth Syndrome: From Mitochondrial Dysfunctions Associated with Aberrant Production of Reactive Oxygen Species to Pluripotent Stem Cell Studies.
    Saric A; Andreau K; Armand AS; Møller IM; Petit PX
    Front Genet; 2015; 6():359. PubMed ID: 26834781
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structural and functional analyses of Barth syndrome-causing mutations and alternative splicing in the tafazzin acyltransferase domain.
    Hijikata A; Yura K; Ohara O; Go M
    Meta Gene; 2015 Jun; 4():92-106. PubMed ID: 25941633
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of a transgenic short hairpin RNA-induced murine model of Tafazzin deficiency.
    Soustek MS; Falk DJ; Mah CS; Toth MJ; Schlame M; Lewin AS; Byrne BJ
    Hum Gene Ther; 2011 Jul; 22(7):865-71. PubMed ID: 21091282
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Barth Syndrome Cardiomyopathy: An Update.
    Pang J; Bao Y; Mitchell-Silbaugh K; Veevers J; Fang X
    Genes (Basel); 2022 Apr; 13(4):. PubMed ID: 35456462
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stem cell models of TAFAZZIN deficiency reveal novel tissue-specific pathologies in Barth Syndrome.
    Sniezek Carney O; Harris KW; Wohlfarter Y; Lee K; Butschek G; Anzmann A; Claypool SM; Hamacher-Brady A; Keller M; Vernon HJ
    bioRxiv; 2024 Apr; ():. PubMed ID: 38746168
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Barth Syndrome: Exploring Cardiac Metabolism with Induced Pluripotent Stem Cell-Derived Cardiomyocytes.
    Fatica EM; DeLeonibus GA; House A; Kodger JV; Pearce RW; Shah RR; Levi L; Sandlers Y
    Metabolites; 2019 Dec; 9(12):. PubMed ID: 31861102
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Loss of tafazzin results in decreased myoblast differentiation in C2C12 cells: A myoblast model of Barth syndrome and cardiolipin deficiency.
    Lou W; Reynolds CA; Li Y; Liu J; Hüttemann M; Schlame M; Stevenson D; Strathdee D; Greenberg ML
    Biochim Biophys Acta Mol Cell Biol Lipids; 2018 Aug; 1863(8):857-865. PubMed ID: 29694924
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.